December 20, 2011 I have received a lot of emails expressing confusion about the White House’s “response” to our petition. I thought I’d outline their underhanded strategy for you in this article.
My petition to the White House  was presented as this:
“Antineoplastons are gene-targeted cancer medications that have completed Phase 2 FDA clinical trials in 2009, with permission granted to enter the final Phase of FDA testing. These medicines are the first in medical history to cure inoperable childhood brainstem glioma with a 27.5%-50% cure rate, among other cures. Other gene-targeted cancer medications have been given accelerated FDA-approval without demonstrating a single cure. Antineoplastons, proven to be non-toxic, remain unapproved for public use. For the sake of public health, the results from Phase 2 clinical trials of Antineoplastons need to be publicly acknowledged by the FDA and audited by Congress. These medicines have been in FDA clinical testing since 1995—it’s time for the general public to have access to them.”
The White House itself did not respond to the petition, they instead asked the FDA to respond. Not only that, the FDA did not address or respond to the petition itself at all. The entire point of petitioning the White House was to petition the White House. If we wanted to petition the FDA, we would have done that (we didn’t do that because we understand that the FDA is a part of the problem). I specifically asked within the petition: “For the sake of public health, the results from Phase 2 clinical trials of Antineoplastons need to be publicly acknowledged by the FDA and audited by Congress.” I worded this very specifically to have the results publicly acknowledged. It makes sense for the FDA to not want this data publicly acknowledged by Congress, because if they did this—the American public and the rest of the world would be furious to find out that nothing is being done about a cancer treatment that has been consistently curing certain types of cancer within Phase 2 FDA clinical trials that have verifiably never before been cured before in the history of medicine.
FDA (Janet Woodcock) petition response Part 1: Thank you for your petition asking the Obama Administration to accelerate the approval of antineoplastons for the treatment of cancer. My response: Thanks, but no thanks Ms. Woodcock, you failed to address anything that the petition was related to and why it was drafted in the first place. For the sake of this petition response, and its purpose, I will be addressing only “childhood diffuse intrinsic brainstem glioma”, as the petition itself specified, in regards to the accelerated approval of antineoplastons.
FDA petition (Janet Woodcock) response Part 2: As you know, cancer treatments go through a careful research process to prove that they are safe and effective. The National Cancer Institute (NCI) has recommended that controlled clinical studies be conducted in order to assess the safety and efficacy of the therapy. To date no randomized, controlled trials showing the effectiveness of antineoplastons have been published in peer-reviewed scientific journals nor have all of the trials needed to approve antineoplastons as a treatment for cancer been conducted.
full article at source:https://www.burzynskimovie.com/index.php?option=com_content&view=article&id=128&Itemid=101
- Antineoplastons, cancer drugs in FDA trials since 1995, results publicly audited by Congress, to gain final FDA-approval (thepressnet.com)
- The Burzynski Clinic (randi.org)
- Dr Hilary Jones Promotes Questionable Burzynski Clinic on TV (quackometer.net)
- The Burzynski Clinic disavows Marc Stephens but not the legal intimidation of bloggers who criticize its therapy [Respectful Insolence] (scienceblogs.com)
- Dr. Stanislaw Burzynski, antineoplastons, and the selling of an orphan drug as a cancer cure (sciencebasedmedicine.org)
- Burzynski The Movie: Hitting you over the head with pseudoscience, just like Burzynski the man (scienceblogs.com)
- New Cancer treatment with Antineoplastons (Ministers reply) (thepressnet.com)
- Marc Stephens issues more threats on behalf of the Burzynski Clinic [Respectful Insolence] (scienceblogs.com)
- What Dr. Stanislaw Burzynski doesn’t want you to know about antineoplastons (scienceblogs.com)
- DARA’s new CEO, board member are familiar faces to the NC biotech firm (medcitynews.com)